Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/17/2025

Treatment for Vaginal Yeast Infections

Uncomplicated Vaginal Yeast Infections

  • The Infectious Diseases Society of America recommends using either a single 150 mg oral dose of fluconazole or any topical azole antifungal agent for 1-7 days, as both are equally effective with >90% cure rates 1
  • Fluconazole 150 mg as a single oral dose achieves >90% response rate 1
  • Topical azole agents, including clotrimazole, miconazole, and others, are equally effective and can be used for 1-7 days 1, 2, 3

Severe Acute Vaginal Yeast Infections

  • For severe presentations, the Infectious Diseases Society of America recommends using fluconazole 150 mg every 72 hours for a total of 2-3 doses 1

Recurrent Vulvovaginal Candidiasis

  • A two-phase treatment approach is recommended, consisting of induction therapy with a topical azole agent or oral fluconazole for 10-14 days, followed by maintenance therapy with fluconazole 150 mg once weekly for 6 months 1, 3, 4
  • Maintenance therapy with fluconazole 150 mg once weekly for 6 months achieves symptom control in >90% of patients 4

Special Situations

  • For C. glabrata infections, the Infectious Diseases Society of America recommends using boric acid 600 mg intravaginal gelatin capsule daily for 14 days as the first choice 1
  • For pregnant women, the Centers for Disease Control and Prevention recommends using only topical azole therapy for 7 days 2
  • For HIV-positive patients, the Infectious Diseases Society of America recommends treating identically to HIV-negative patients 1

Diagnostic Confirmation Before Treatment

  • The Infectious Diseases Society of America recommends confirming diagnosis with a wet-mount preparation with 10% KOH showing yeast or pseudohyphae, normal vaginal pH (≤4.5), or vaginal cultures for Candida before starting empiric therapy 1, 4

Over-the-Counter Considerations

  • The Centers for Disease Control and Prevention recommends that self-treatment with over-the-counter agents should only be advised for women previously diagnosed with VVC who have recurrent identical symptoms 1, 5

Partner Treatment

  • The Infectious Diseases Society of America recommends that routine treatment of sex partners is NOT recommended, as VVC is not sexually transmitted 1, 5